Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial.
Saved in:
| Title: | Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial. |
|---|---|
| Authors: | Katz MHG; The University of Texas MD Anderson Cancer Center, Houston., Shi Q; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota., Meyers J; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota., Herman JM; Northwell Cancer Institute, National Cancer Institute Community Oncology Research Program, Manhasset, New York., Chuong M; Miami Cancer Institute, Miami, Florida., Wolpin BM; Dana-Farber/Partners CancerCare, Boston, Massachusetts., Ahmad S; University of Cincinnati, Cincinnati, Ohio., Marsh R; NorthShore University Health System, Evanston, Illinois., Schwartz L; Columbia University, New York, New York., Behr S; University of California, San Francisco., Frankel WL; The Ohio State University Arthur G James Cancer Hospital, Columbus., Collisson E; University of California, San Francisco., Leenstra J; St. Mary's Hospital, Oneida, Wisconsin., Williams TM; City of Hope National Medical Center, Duarte, California., Vaccaro G; Oregon Health and Science University, Portland., Venook A; University of California, San Francisco., Meyerhardt JA; Dana-Farber/Partners CancerCare, Boston, Massachusetts., O'Reilly EM; Memorial Sloan Kettering Cancer Center, New York, New York. |
| Source: | JAMA oncology [JAMA Oncol] 2022 Sep 01; Vol. 8 (9), pp. 1263-1270. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35834226 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Katz+MHG%22">Katz MHG</searchLink>; The University of Texas MD Anderson Cancer Center, Houston.<br /><searchLink fieldCode="AU" term="%22Shi+Q%22">Shi Q</searchLink>; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Meyers+J%22">Meyers J</searchLink>; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Herman+JM%22">Herman JM</searchLink>; Northwell Cancer Institute, National Cancer Institute Community Oncology Research Program, Manhasset, New York.<br /><searchLink fieldCode="AU" term="%22Chuong+M%22">Chuong M</searchLink>; Miami Cancer Institute, Miami, Florida.<br /><searchLink fieldCode="AU" term="%22Wolpin+BM%22">Wolpin BM</searchLink>; Dana-Farber/Partners CancerCare, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Ahmad+S%22">Ahmad S</searchLink>; University of Cincinnati, Cincinnati, Ohio.<br /><searchLink fieldCode="AU" term="%22Marsh+R%22">Marsh R</searchLink>; NorthShore University Health System, Evanston, Illinois.<br /><searchLink fieldCode="AU" term="%22Schwartz+L%22">Schwartz L</searchLink>; Columbia University, New York, New York.<br /><searchLink fieldCode="AU" term="%22Behr+S%22">Behr S</searchLink>; University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Frankel+WL%22">Frankel WL</searchLink>; The Ohio State University Arthur G James Cancer Hospital, Columbus.<br /><searchLink fieldCode="AU" term="%22Collisson+E%22">Collisson E</searchLink>; University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Leenstra+J%22">Leenstra J</searchLink>; St. Mary's Hospital, Oneida, Wisconsin.<br /><searchLink fieldCode="AU" term="%22Williams+TM%22">Williams TM</searchLink>; City of Hope National Medical Center, Duarte, California.<br /><searchLink fieldCode="AU" term="%22Vaccaro+G%22">Vaccaro G</searchLink>; Oregon Health and Science University, Portland.<br /><searchLink fieldCode="AU" term="%22Venook+A%22">Venook A</searchLink>; University of California, San Francisco.<br /><searchLink fieldCode="AU" term="%22Meyerhardt+JA%22">Meyerhardt JA</searchLink>; Dana-Farber/Partners CancerCare, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22O'Reilly+EM%22">O'Reilly EM</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101652861%22">JAMA oncology</searchLink> [JAMA Oncol] 2022 Sep 01; Vol. 8 (9), pp. 1263-1270. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101652861 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2374-2445 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223742437%22">23742437 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35834226 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1001/jamaoncol.2022.2319 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1263 Titles: – TitleFull: Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Katz MHG – PersonEntity: Name: NameFull: Shi Q – PersonEntity: Name: NameFull: Meyers J – PersonEntity: Name: NameFull: Herman JM – PersonEntity: Name: NameFull: Chuong M – PersonEntity: Name: NameFull: Wolpin BM – PersonEntity: Name: NameFull: Ahmad S – PersonEntity: Name: NameFull: Marsh R – PersonEntity: Name: NameFull: Schwartz L – PersonEntity: Name: NameFull: Behr S – PersonEntity: Name: NameFull: Frankel WL – PersonEntity: Name: NameFull: Collisson E – PersonEntity: Name: NameFull: Leenstra J – PersonEntity: Name: NameFull: Williams TM – PersonEntity: Name: NameFull: Vaccaro G – PersonEntity: Name: NameFull: Venook A – PersonEntity: Name: NameFull: Meyerhardt JA – PersonEntity: Name: NameFull: O'Reilly EM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2022 Sep 01 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2374-2445 Numbering: – Type: volume Value: 8 – Type: issue Value: 9 Titles: – TitleFull: JAMA oncology Type: main |
| ResultId | 1 |